MICRONAUT-S MDR MRGN3 - an extended spectrum of antibiotics and carbapenemase phenotyping
|
|
|
|
MICRONAUT-S MDR MRGN3 (multi drug resistant Gram negatives) this product combines susceptibility testing, based on broth microdilution against an extended spectrum of antibiotics, with phenotypic identification.
Ceftolozane-tazobactam, ceftazidime-avibactam and colistin are included in the latest version The MICRONAUT MDR/MRGN plate offers; > Detection of low level carbapenem resistance > Colistin by broth microdilution > Phenotypical detection of KPC, MBL, OXA-48 like and Amp-C > Broth microdilution susceptibility testing against 17 antibiotics/antibiotic combinations > new antibiotics Ceftolozane– tazobactam and ceftazidime-avibactam included > MICRONAUT software option available for the analysis, interpretation and recording of results. |
ANTIBIOTIC SPECTRUM
Amikacin Cefotaxime Ceftazidime Ceftazidime + 350 μg/ml 3-APB Ceftazidime/Avibactam Ceftolozan/Tazobactam Chloramphenicol Ciprofloxacin Colistin Fosfomycin Imipenem Levofloxacin Meropenem Meropenem + 0,4 mM EDTA Meropenem + 350 μg/ml 3-APB Piperacillin Piperacillin/Tazobactam Temocillin Tigecyclin Trimethoprim/Sulfamethoxazole |
click for plate layout
| e1-100-040.frx.pdf |
MICRONAUT-S Beta Lactamases - Phenotypical detection of multiple ß-Lactamases in a single test system
|
MICRONAUT-S Beta Lactamases On a single plate, this product not only identifies (phenotypically) KPC, MBL, OXA-48, ESBL & AmpC but also provides valuable MIC information.
NEW: Extended spectrum of antibiotics by Temocillin and Ertapenem-/Meropenem screening concentrations for detection of OXA-48 like Type D-carbapenemases EUCAST screening cut-off values are included for carbapenemase producing Enterobacteriaceae |
ANTIBIOTIC SPECTRUM - MIC values
Ceftazadime Cefotaxime Cefepime Meropenem Ertapenem Temocillin click for plate layout
| ||
The MICRONAUT-S ß-Lactamases plate offers - Resistance determination of all relevant gram-negative bacteria (enterobacteria, Aeromonas, non-fermenters) against 6 antibiotics and 7 antibiotics combinations in a standard micro-dilution procedure
> Phenotypical detection of MBL using Meropenem +/- EDTA
> Phenotypical detection of ESBL (using 3 cephalosporins +/- clavulanate
> Phenotypical detection of KPC using Meropenem +/- 3- Amino-Phenyl-Borat (3- APB)
> Phenotypical detection of AMP-C using 3 cephalosporins +/- 3- Amino-Phenyl-Borat (3- APB)
> Detection of OXA-48 like type D-carbapenemases based on temocillin high-level resistance
> Detection of low-level carbapenem resistance by introduction of ertapenem-/meropenem screening concentrations
> Analysis and interpretation after visual or automated reading
> MICRONAUT software for the analysis and interpretation after automated reading with:
> Phenotypical detection of MBL using Meropenem +/- EDTA
> Phenotypical detection of ESBL (using 3 cephalosporins +/- clavulanate
> Phenotypical detection of KPC using Meropenem +/- 3- Amino-Phenyl-Borat (3- APB)
> Phenotypical detection of AMP-C using 3 cephalosporins +/- 3- Amino-Phenyl-Borat (3- APB)
> Detection of OXA-48 like type D-carbapenemases based on temocillin high-level resistance
> Detection of low-level carbapenem resistance by introduction of ertapenem-/meropenem screening concentrations
> Analysis and interpretation after visual or automated reading
> MICRONAUT software for the analysis and interpretation after automated reading with:
- Indication of confirmed resistance mechanisms (ESBL | MBL | KPC | AMP-C | OXA-48 like) by MIC quotient assessment and determination of temocillin high-level resistance
- Phenotypcal confirmation of resistance mechanisms even at the occurrence of multiple ß-Lactamases
|
|
|
